IGF1 and type 2 diabetes mellitus: However, poorly managed T2D patients exhibit an increase in IGFBP-3 glycation, which raises the affinity for IGF-1, and additional sialylation that has the opposite effect, namely to reduce IGF-1 affinity [15].